SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page1234567Next Page
2026-09-04CDT8-KCDT Equity Amends Sarborg Investment Agreement and Executes Short-term Convertible Note FinancingMEDIUM
On August 31, 2026, CDT Equity Inc. entered into an amendment to its Securities Purchase Agreement with Sarborg Limited. Under the revised terms, CDT Equity will acquire a 20% equity interest in Sarborg for $8,000,000. Notably, $1,750,000 of this consideration will be satisfied through the issuance of CDT Common Stock,...
Nano CapBiotechnologyPartnership / Licensing
2026-09-04CURX8-KCuranex Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price RequirementMEDIUM
On September 3, 2026, Curanex Pharmaceuticals Inc (NASDAQ: CURX) received formal notification from the Nasdaq Listing Qualifications Department confirming that the company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). The company was originally notified of i...
BiotechnologyOthers
Previous Page1234567Next Page